Repligen
RGEN
#1868
Rank
HK$86.63 B
Marketcap
HK$1,364
Share price
6.13%
Change (1 day)
20.72%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : HK$6.57 Billion

According to Repligen 's latest financial reports the company's total liabilities are HK$6.57 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$6.56 B-1.34%
2024-12-31HK$6.65 B-1.67%
2023-12-31HK$6.76 B39.47%
2022-12-31HK$4.85 B2.28%
2021-12-31HK$4.74 B63.71%
2020-12-31HK$2.89 B9.3%
2019-12-31HK$2.65 B112.81%
2018-12-31HK$1.24 B4.9%
2017-12-31HK$1.18 B27.44%
2016-12-31HK$0.93 B411.77%
2015-12-31HK$0.18 B41.73%
2014-12-31HK$0.12 B12.24%
2013-12-31HK$0.11 B14.58%
2012-12-31HK$99.87 M
2011-03-31HK$40.5 M-1.59%
2010-03-31HK$41.15 M14.67%
2009-03-31HK$35.89 M-2.54%
2008-03-31HK$36.82 M33.24%
2007-03-31HK$27.63 M12.04%
2006-03-31HK$24.66 M-4.61%
2005-03-31HK$25.86 M35.53%
2004-03-31HK$19.08 M9.05%
2003-03-31HK$17.49 M-15.88%
2002-03-31HK$20.79 M112.22%
2001-03-31HK$9.8 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$907.44 B 13,696.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$473.70 B 7,102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$861.66 B 13,000.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$512.53 B 7,692.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.61 B-90.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$8.99 B 36.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$13.06 B 98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$3.75 B-42.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$42.38 B 544.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$36.43 B 454.03%๐Ÿ‡บ๐Ÿ‡ธ USA